Kite.com
Kite.com

Kite.com

hand in laptop pointing to email icon

Your dream job…could be 1 update away

Kite.com High Paying Jobs, Compensation Information and Expert Network Connections

lightbulbWhat are the highest paying jobs at Kite.com?

Kite Pharma is an American biotechnology company that develops cancer immunotherapy products, with a primary focus on genetically-engineered autologous T cell therapy with chimeric antigen receptors. Based in Santa Monica, California, it is a subsidiary of Gilead Sciences.

The company was founded in 2009 by Arie Belldegrun, M.D., FACS, an Israeli-American oncologist, who served as the company's chairman, president and chief executive officer.[better source needed] Belldegrun had a co-founder in Joshua Kazam, who took on the role of Director.

On August 28, 2017, Gilead Sciences announced that it would acquire Kite Pharma for $11.9 billion in an all-cash deal, equating to $180 cash per share. The deal was expected to add the promising CAR-T candidate to Gilead's existing portfolio. The acquisition was completed in October 2017, when Kite Pharma's therapy, Yescarta, became the first CAR-T therapy approved by the FDA for the treatment of adult patients with relapsed or refractory large B-cell lymphoma after two or more lines of systemic therapy.

In 2017, MIT Technology Review ranked Kite Pharma 7th in its annual list of the preceding year's 50 Smartest Companies.

Snapshot

Founded2013
stats icon
Total value of jobs:
$575,000
stats icon
Average Pay:
$95,833

Similar Companies